Drug treatments for covid-19: living systematic review and network meta-analysis
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
[HTML][HTML] COVID-19 and kidney disease: insights from epidemiology to inform clinical practice
V Mahalingasivam, G Su, M Iwagami… - Nature Reviews …, 2022 - nature.com
Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …
challenges faced by patients with kidney disease and their caregivers. These studies …
[PDF][PDF] Therapeutics and COVID-19: living guideline, 16 September 2022
World Health Organization - 2022 - apps.who.int
As of August 2022, there have been over 572 million confirmed cases of COVID-19 (9). The
pandemic has thus far claimed approximately 6.39 million lives (9). Vaccination is having a …
pandemic has thus far claimed approximately 6.39 million lives (9). Vaccination is having a …
A living WHO guideline on drugs for covid-19
This living guideline by Arnav Agarwal and colleagues (BMJ 2020; 370: m3379, doi:
10.1136/bmj. m3379) was last updated on 22 April 2022, but the infographic contained two …
10.1136/bmj. m3379) was last updated on 22 April 2022, but the infographic contained two …
A living WHO guideline on drugs for covid-19
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published …
earlier versions (available as data supplements). New recommendations will be published …
Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
Prophylaxis against covid-19: living systematic review and network meta-analysis
Updates This is the second version (first update) of the living systematic review, replacing
the previous version (available as a data supplement). When citing this paper please …
the previous version (available as a data supplement). When citing this paper please …
Therapeutic monoclonal antibodies for COVID-19 management: an update
VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …
affected more than 529 million people, and today the world is facing different mutant strains …
[HTML][HTML] COVID-19: systemic pathology and its implications for therapy
Q Shen, J Li, Z Zhang, S Guo, Q Wang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Responding to the coronavirus disease 2019 (COVID-19) pandemic has been an
unexpected and unprecedented global challenge for humanity in this century. During this …
unexpected and unprecedented global challenge for humanity in this century. During this …
[HTML][HTML] The global impact of COVID-19 on solid organ transplantation: two years into a pandemic
A Nimmo, D Gardiner, I Ushiro-Lumb, R Ravanan… - …, 2022 - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …